Dillon Martinson

Special Counsel
dmartinson@cooley.com
Full contact info

About Dillon

Dillon Martinson is a special counsel in the firm’s CFIUS practice. Dillon advises clients on national security matters, specializing in helping clients navigate voluntary and mandatory CFIUS filings. Previously, Dillon served as a senior policy advisor at the US Department of the Treasury where he led over 60 CFIUS reviews and negotiated numerous complex and confidential mitigation agreements between transaction parties and the government. Dillon’s unique perspective provides clients with an in-depth understanding of the CFIUS process and broader government viewpoints on national security. 

View full bio

Experience

Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger

Cooley Advises on Candid Therapeutics’ $370 Million Capital Raise, Three-Way Merger

September 9, 2024

Cooley advised Candid Therapeutics, a biotechnology company dedicated to developing potentially transformative drugs to address autoimmune diseases, on its $370 million debut capital raise and three-way merger with Vignette Bio and TRC 2004.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Edmond Lay
Associate, San Diego
Matthew D. Silverman
Special Counsel, Santa Monica
Ben Beerle
Partner, San Francisco
Leina Verrier
Associate, Santa Monica
Jayden Martinez
Associate, Colorado
Jack Whitaker
Associate, San Diego
Dillon Martinson
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Megan Browdie
Partner, Washington, DC
Nicholas Orr
Associate, Los Angeles
Sharon Connaughton
Special Counsel, Washington, DC
Patricia Myers
Paralegal Specialist, Colorado
Linh Nguyen
Associate, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Kate Walther
Paralegal Specialist, San Diego
John Sellers
Partner, Palo Alto
Katie Kissner
Quantitative Analyst, San Francisco
Jennifer Shanley
Special Counsel, New York
Natasha Leskovsek
Of Counsel, Washington, DC

Related Practices & Industries

Life Sciences
Private Equity
Capital Markets
Mergers and Acquisitions
Emerging Companies
Healthcare
Life Sciences Corporate Partnering and Licensing
Life Sciences and Healthcare Regulatory
Biotechnology
CFIUS
Compensation and Benefits
Labor and Employment
Tax
Antitrust and Competition

PruVen Capital Closes Oversubscribed $378.5 Million Fund II

PruVen Capital Closes Oversubscribed $378.5 Million Fund II

September 3, 2024

Cooley advised PruVen Capital, an independent venture capital firm whose investors are exclusively global leaders in financial services and insurance, on the close of its oversubscribed $378.5 million second fund.

Read more

Related contacts

John Clendenin
Partner and Business Department Vice Chair, Palo Alto
Hongru Sun
Associate, Palo Alto
Paul Roberts
Of Counsel, San Francisco
Stacey Song
Partner, New York
Christopher Kimball
Partner, Washington, DC
Stephanie Li
Associate, Beijing
Dillon Martinson
Special Counsel, Washington, DC

Related Practices & Industries

Fund Formation
CooleyREG
Venture Capital
CFIUS
Tax

Outpace Bio Announces $144 Million Oversubscribed Series B

Outpace Bio Announces $144 Million Oversubscribed Series B

August 1, 2024

Cooley advised Outpace Bio, a cell therapy company using unrivaled artificial intelligence-powered protein design to program immune cells for improved function inside patients battling solid tumors, on its $144 million oversubscribed Series B financing.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Christopher Kimball
Partner, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Lucy Bauer
Associate, Seattle
Karen Gustavson
Associate, Seattle
Millie Heuer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

Artificial Intelligence
Healthcare
Emerging Companies
Tax
CFIUS
Capital Markets

Cache DNA Closes Seed Financing Round

Cache DNA Closes Seed Financing Round

May 7, 2024

Cooley advised Cache DNA, a life sciences company revolutionizing biological sample and data storage infrastructure, on the close of its seed round.

Read more

Related contacts

Matthew Bartus
Partner, San Francisco
David Fletcher
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Kevin King
Partner, Washington, DC
Dillon Martinson
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Parker Armsby
Associate, New York
Umer Chaudhry
Associate, Washington, DC
Carl Min
Associate, San Francisco
Sarah Oliai
Associate, Washington, DC
Michael Suyat
Senior Paralegal, San Francisco
Ron Metzger
Paralegal Specialist, San Francisco

Related Practices & Industries

Life Sciences
Emerging Companies
CFIUS

Nuvalence Announces Acquisition by EY

Nuvalence Announces Acquisition by EY

April 29, 2024

Cooley advised Nuvalence, a technology consultancy firm, on its acquisition by EY to accelerate the delivery of platform engineering, product development, and generative artificial intelligence platform-enabled services to organizations across industries and sectors.

Read more

Related contacts

Joshua Holleman
Partner, Washington, DC
Danielle Joe
Associate, Washington, DC
Vicky Kandabarow
Associate, Washington, DC
Megan Browdie
Partner, Washington, DC
Adam Dinow
Partner, New York
Annie Froehlich
Partner, Washington, DC
Len Jacoby
Partner, New York
Christopher Kimball
Partner, Washington, DC
Nyron J. Persaud
Partner, New York
Lei Shen
Partner, Chicago
Rachel Thorn
Partner, New York
Jeffrey J. Tolin
Partner, New York
Bryan Berman
Special Counsel, Colorado
Peter Crain
Special Counsel, Reston
Dillon Martinson
Special Counsel, Washington, DC

Related Practices & Industries

Mergers and Acquisitions
Emerging Companies
Technology Transactions
Technology
Artificial Intelligence
Asia
Real Estate
Labor and Employment
CFIUS
Tax
Cyber/Data/Privacy
Compensation and Benefits
Antitrust and Competition
Education
Commercial Litigation
View more

Admissions and credentials

District of Columbia

Virginia

Rankings and accolades

Chambers USA: International Trade: CFIUS Experts – Nationwide (2023–2024)